August 28, 2017 / 8:46 AM / 2 months ago

BRIEF-Cyclopharm says HY loss attributable $1.4 million

Aug 28 (Reuters) - Cyclopharm Ltd

* Declared interim dividend of 0.5 cents per share

* Company expects modest underlying sales and earnings growth in 2017 and to maintain a healthy capital position

* HY loss attributable $1.4 million

* HY revenues from ordinary activities down 6 percent to $6.1 million Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below